Normal Size Ovary Carcinoma Syndrome with Inguinal Ovarian Cancer Lymph Node Metastases - A Case Report and Literature Review

被引:10
作者
Bacalbasa, Nicolae [1 ]
Balescu, Irina [2 ]
Balalau, Cristian [1 ,3 ]
Ionescu, Olivia [4 ]
Stoica, Claudia [5 ]
机构
[1] Carol Davila Univ Med & Pharm, Dept Obstet & Gynecol, Bucharest, Romania
[2] Ponderas Acad Hosp, Dept Gen Surg, Bucharest, Romania
[3] Sf Pantelimon Clin Hosp, Dept Gen Surg, Bucharest, Romania
[4] Fichtelgebirge Clin, Dept Obstet & Gynecol, Marktredwitz, Germany
[5] Ilfov Clin Cty Hosp, Dept Gen Surg, Bucharest, Romania
来源
IN VIVO | 2018年 / 32卷 / 02期
关键词
Normal size ovarian cancer; lymphatic spread; inguinal lymph node metastases; SINGLE-CENTER EXPERIENCE; CYTOREDUCTIVE SURGERY; ADVANCED-STAGE; LYMPHADENOPATHY; MANAGEMENT; PROGNOSIS; RESECTION; PART;
D O I
10.21873/invivo.11250
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Inguinal lymph node mass as the first sign in patients with ovarian cancer represents a rare situation, with only few cases being reported so far. We present the case of a 46-year-old patient who presented for the apparition of bilateral inguinal tumoral masses in the absence of any other pathological signs. The biopsy revealed the presence of an adenocarcinoma with probable genital origin; however, neither the gynaecological examination nor the computed tomography demonstrated the presence of any suspect lesion. The patient was submitted to a positron emission computed tomography which revealed a high capitation in both adnexal areas as well as at the level of the inguinal lymph nodes. The patient was submitted to surgery, the frozen section of the adnexas confirming the ovarian origin of the tumor. Complete cytoreduction to no residual disease was successfully performed. At one-year follow-up the patient is free of any recurrent disease.
引用
收藏
页码:385 / 389
页数:5
相关论文
共 19 条
[1]  
Bacalbasa N, WORLD J SURG ONCOL, V13, P235
[2]  
Bacalbasa N, 2015, ANTICANCER RES, V35, P6919
[3]  
Bacalbasa N, 2015, ANTICANCER RES, V35, P5649
[4]  
Bacalbasa N, 2015, ANTICANCER RES, V35, P5097
[5]  
Bacalbasa N, 2015, ANTICANCER RES, V35, P4125
[6]  
Bacalbasa N, 2015, ANTICANCER RES, V35, P4099
[7]  
Bacalbasa N, 2015, ANTICANCER RES, V35, P2315
[8]  
Berek JS, 1994, PRACTICAL GYNECOLOGI, V3rd, P466
[9]   Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: A meta-analysis [J].
Bristow, RE ;
Tomacruz, RS ;
Armstrong, DK ;
Trimble, EL ;
Montz, FJ .
JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (05) :1248-1259
[10]  
Deka P., 2013, J Cancer Ther Res, V2, P3, DOI [10.7243/2049-7962-2-3, DOI 10.7243/2049-7962-2-3]